Innovator International Developed Power Buffer ETF - November - INOV STOCK NEWS

Inovalon (Nasdaq: INOV) announced its annual ScriptMed® Conference will be held virtually from November 8-9, 2021. The event will feature industry leaders discussing technology's role in healthcare data sharing and improving patient care.

Keynote speakers include executives from organizations like AllianceRx Walgreens Prime and Walmart. The conference aims to explore how data-driven approaches can enhance patient outcomes and operational efficiency within the specialty pharmacy landscape.

Inovalon announced that its annual Client Congress will be held virtually on October 18-19, 2021, featuring keynotes from industry leaders including Seema Verma, Frank Slootman, and Dr. Kyu Rhee. This event aims to address critical issues in U.S. healthcare, showcasing over 20 sessions with experts from major organizations like Aetna/CVS Health and Google. The focus will be on data-driven strategies for improving healthcare delivery. Last year saw record attendance, reflecting the event's significance in the healthcare landscape.

On September 21, 2021, CorEvitas announced an expanded collaboration with Inovalon (NASDAQ: INOV) to enhance data-driven healthcare analytics for patients with rheumatoid arthritis and psoriasis. This partnership combines CorEvitas' clinical data with Inovalon's MORE² Registry®, significantly improving insights into patient demographics, clinical characteristics, and healthcare resource utilization. The initiative aims to connect clinical measures with economic outcomes, optimizing patient care and informing clinical development strategies.

Inovalon (Nasdaq: INOV) announced its acquisition by an equity consortium led by Nordic Capital, with a total enterprise value of approximately $7.3 billion. Stockholders will receive $41.00 per share in cash, representing a 25.3% premium over the closing price on July 26, 2021. The deal, approved unanimously by Inovalon's Board, awaits stockholder votes and is expected to close in late 2021 or early 2022. Post-acquisition, Inovalon will operate as a private entity, aiming for innovation and growth under CEO Keith Dunleavy.

Inovalon (Nasdaq: INOV), a leader in cloud-based healthcare solutions, announced a presentation by CEO Keith Dunleavy and CFO Jonathan Boldt at the KeyBanc Technology Leadership Forum on August 10, 2021, at 12:00 noon ET. The event will be held virtually in a fireside chat format and will be accessible via a live webcast on Inovalon's Investor Relations website. An archived version of the presentation will also be available for a limited time. Management plans to conduct one-on-one meetings with registered institutional investors throughout the day.

Inovalon reported strong Q2 2021 results, with revenue of $190.4 million, a 17% increase YOY. Subscription-based revenue hit $168.7 million, making up 89% of total revenue, reflecting a 19% YOY growth. Net income reached $9.6 million, translating to $0.06 per share. Non-GAAP net income was $27.9 million, or $0.19 per share, up 27% YOY. Inovalon raised its full-year revenue guidance to $760 million to $778 million, anticipating a 14% to 17% growth rate. Cash balance stood at $117.9 million, with a net debt leverage ratio improving to 3.17x.

Inovalon (Nasdaq: INOV) announced it will conduct a conference call on July 28, 2021, at 5:00 p.m. ET to review its second quarter 2021 financial results. This call follows the release of its financial results and will be accessible at (855) 783-2604, with international callers using (631) 485-4882. Investors can also access a replay on Inovalon's website. The company emphasizes its role in data-driven healthcare through the Inovalon ONE® Platform, connecting healthcare data and analytics for improved patient care and financial performance.

Inovalon has appointed Eron S. Kelly as its new Corporate President, effective June 28, 2021. Kelly brings over 20 years of experience from Amazon and Microsoft, where he led significant growth in cloud technologies. His role will encompass management of Inovalon's business units, focusing on growth, product offerings, and customer relationships. The CEO, Keith Dunleavy, expressed confidence in Kelly’s ability to drive the company's expansion amidst substantial opportunities in both U.S. and global markets. Inovalon specializes in data-driven healthcare solutions.

Inovalon (Nasdaq: INOV) has extended its partnership with Walmart (NYSE: WMT) through 2028, enhancing the use of the Inovalon ONE® Platform across Walmart's pharmacy network. This agreement will expand the application of ScriptMed® Cloud to improve clinical care management for complex patients. Initially begun in 2020, this collaboration allows Walmart to leverage Inovalon’s cloud-based capabilities to drive better healthcare outcomes and operational efficiencies. The partnership underscores Walmart's commitment to innovative healthcare solutions that deliver quality care.